Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer’s recent earnings report dazzled investors, but not everything sparkles like it seems. Unusual items worth ₹1.7b ...

Many investors turn to Benjamin Graham's so-called “Graham number” to calculate the fair price of a stock. The Graham number ...

Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...